Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.

Intensive Care Medicine Experimental is a premier open-access journal dedicated to advancing research and clinical practice within the realms of critical care, intensive care medicine, and emergency medicine. Published by SPRINGER, this influential journal has been committed to dispensing high-quality, peer-reviewed research since its inception in 2013, reflecting its progressive approach to open-access publishing and enhancing global accessibility to vital medical information. With a notable impact factor and categorically established Q1 rankings in both Critical Care and Emergency Medicine, as well as Q2 in Physiology (medical), the journal underscores its significance in disseminating groundbreaking studies and innovations. Positioned prominently within the medical literature, Intensive Care Medicine Experimental ranks 16th in Emergency Medicine and 27th in Critical Care, providing a vital platform for researchers, clinicians, and students alike to explore and share cutting-edge research findings that aim to improve patient outcomes. The journal's dedication to fostering collaboration and dialogue among professionals makes it an essential resource in the evolving landscape of intensive care and emergency medical disciplines.

Slovenian Veterinary Research, published by the University of Ljubljana, serves as a significant platform for the dissemination of research within the veterinary field. With an ISSN of 1580-4003 and an E-ISSN of 2385-8761, this open-access journal has made its content freely available to the global research community since 2021, enhancing accessibility and engagement. The journal's scope includes a diverse range of topics relevant to veterinary science, aiming to foster innovation and collaboration among researchers, professionals, and students in the field. Although currently categorized in the Q4 quartile for veterinary studies, the journal is committed to improving its impact and visibility, particularly as it converges on its upcoming years of operation from 2007 to 2024. As it strives to elevate its Scopus ranks, currently positioned at rank #162/194 in General Veterinary, Slovenian Veterinary Research provides a vital resource for advancing knowledge and best practices in veterinary medicine. For anyone interested in the latest veterinary research trends and findings emanating from Slovenia and beyond, this journal represents an essential source of information.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

LAB ANIMAL, a journal published by NATURE PORTFOLIO, is a prominent source of knowledge in the fields of animal science and veterinary medicine. With its ISSN 0093-7355 and E-ISSN 1548-4475, it serves as a critical platform for researchers, professionals, and students dedicated to the advancement of laboratory animal science. Despite being categorized in the Q4 quartile for Animal Science and Zoology and Q3 for Veterinary (Miscellaneous) in 2023, its contributions are invaluable, reflecting rigorous research and development essential for improving laboratory animal care and ethical research practices. The journal aims to foster innovation and responsive dialogue in an evolving landscape of animal research, promoting a more humane and scientifically sound approach. Although it currently operates under a subscription-based model, LAB ANIMAL continues to be an essential resource for the academic community, providing insights that are integral to advancing both veterinary and animal sciences. The journal has consistently published research since its inception in 1995, engaging a diverse audience with comprehensive studies and discussions that impact the future of the field.

JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY is a distinguished publication presented by the POLISH PHYSIOLOGICAL SOC, dedicated to advancing the fields of physiology and pharmacology. Since its inception in 1991, this journal has maintained a commitment to disseminating vital research findings, contributing to the growing body of knowledge essential for understanding complex biological systems and their interactions with pharmacological agents. With a consistent focus on interdisciplinary studies, the journal holds a Q3 categorization in both Medicine and Pharmacology as well as Physiology for 2023, reflecting its relevance in these crucial fields. Although specific access options are not available, the journal's robust indexing and rankings in Scopus signify its credibility and the high caliber of its contributions, appealing to researchers, professionals, and students alike. Operating from the picturesque Jagiellonian University in Krakow, Poland, this journal not only enriches the academic landscape but also fosters global collaboration and innovation in the life sciences.

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

Molecular Pain, published by SAGE Publications Inc, is a leading open access journal dedicated to advancing the field of pain research and management. Since its establishment in 2005, the journal has provided a vital platform for researchers and professionals to share significant findings in anesthesiology and pain medicine, cellular and molecular neuroscience, and molecular medicine. With an impressive impact factor and a strong reputation as evidenced by its Q1 categorization in Anesthesiology and Pain Medicine, this journal ranks among the top resources in its field, positioned in the 79th percentile for Pain Medicine and holding a noteworthy presence within the academic community. The journal’s commitment to disseminating high-quality research underlines its relevance and importance, making it a crucial reference for students, scientists, and clinicians alike. By promoting a deeper understanding of pain mechanisms, Molecular Pain fosters interdisciplinary collaboration and encourages innovative therapeutic approaches, ultimately enhancing patient care and outcomes.